GILDER GAGNON HOWE & CO LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 902464 New York, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,342,272

-$43,034 QoQ

Shares Held

28,573

-2.8% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#80

of 414 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GILDER GAGNON HOWE & CO LLC holds $353,222,516 across 21 Biotechnology names. MDGL ranks #8 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	269,051	$80,992,422
2	NKTR	Nektar Therapeutics	600,873	$41,946,944
3	BBIO	BridgeBio Pharma, Inc.	548,926	$40,884,008
4	ARQT	Arcutis Biotherapeutics, Inc.	1,313,211	$34,432,392
5	CYTK	Cytokinetics Inc	400,245	$34,096,871
6	KYMR	Kymera Therapeutics, Inc.	229,053	$26,265,507
7	QURE	uniQure N.V.	530,979	$24,456,892
8	MDGL	Madrigal Pharmaceuticals, Inc. This page	28,573	$15,342,272

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,342,272	28,573	-2.8%	Shares	Sole	2026-08-14
2026-03-31	$15,385,306	29,391	-12.2%	Shares	Sole	2026-05-15
2025-12-31	$19,489,755	33,468	+8.5%	Shares	Sole	2026-02-17
2025-09-30	$14,148,743	30,848	-2.2%	Shares	Sole	2025-11-14
2025-06-30	$9,549,199	31,553	-0.3%	Shares	Sole	2025-08-14
2025-03-31	$10,485,416	31,656	-12.5%	Shares	Sole	2025-05-15
2024-12-31	$11,160,359	36,168	-5.2%	Shares	Sole	2025-02-14
2024-09-30	$8,092,585	38,133	-0.6%	Shares	Sole	2024-11-14
2024-06-30	$10,751,700	38,377	-1.8%	Shares	Sole	2024-08-14
2024-03-31	$10,436,724	39,083	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.